• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWWD:GR

152.7600 EUR 3.6400 2.44%

As of 15:45:03 ET on 10/21/2014.

Snapshot for DWS Biotech (DWWD)

Open: 150.3300 High - Low: 156.6300 - 148.8000 Primary Exchange: Frankfurt
Volume: 186 52-Week Range: 102.2800 - 159.9500 Beta vs NBI: 0.9524

ETF Chart for DWWD

No chart data available.
  • DWWD:GR 156.6300
  • 1D
  • 1M
  • 1Y
149.1200
Interactive DWWD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWWD

DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.

Inception Date: 1999-08-16 Telephone: Tel. 49-1803-10111011
Managers: NOUSHIN IRANI TURNER
Web Site: www.dws.de

Fundamentals for DWWD

NAV (on 2014-10-21) 150.8100
Assets (M) (on 2014-10-21) 303.8458
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 1.29
Average 52-Week % Premium -0.7543
Fund Leveraged N

Dividends for DWWD

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-10-01) 0.0237
Dividend Yield (ttm) 0.02%

Performance for DWWD

1-Month -2.15% 1-Year +35.95%
3-Month +18.33% 3-Year +42.16%
Year To Date +29.34% 5-Year +28.98%
Expense Ratio 1.70

Top Fund Holdings for DWWD

Filing Date: 07/31/2014
Name Position Value % of Total
Celgene Corp 445,000 29,349,933 9.746%
Gilead Sciences Inc 390,000 27,309,318 9.069%
Biogen Idec Inc 102,317 26,317,943 8.739%
Alexion Pharmaceuticals Inc 138,600 16,937,471 5.624%
Vertex Pharmaceuticals Inc 223,050 15,322,406 5.088%
Illumina Inc 105,000 12,938,032 4.296%
Amgen Inc 125,000 12,133,231 4.029%
Regeneron Pharmaceuticals Inc 47,000 11,305,405 3.754%
BioMarin Pharmaceutical Inc 230,000 10,490,294 3.484%
Salix Pharmaceuticals Ltd 80,000 8,078,841 2.683%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil